<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Keratoconus</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Keratoconus</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Keratoconus</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Laura L Wayman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Deborah S Jacobs, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane Givens, MD, MSCE</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 06, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H7023364"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Keratoconus is a noninflammatory disorder of the cornea of unknown etiology. It is characterized by progressive thinning and cone-shaped protrusion of the cornea leading to visual impairment (<a class="graphic graphic_picture graphicRef105326" href="/d/graphic/105326.html" rel="external">picture 1</a>). Patients may present with blurry vision or a sudden decrease in visual acuity. Corrective lenses may be difficult to fit and require frequent changes due to progressive myopia and irregular astigmatism. Visual impairment can be managed initially with corrective lenses but may require corneal cross-linking to prevent disease progression or penetrating keratoplasty in more advanced disease.</p><p class="headingAnchor" id="H7023370"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Patients present at puberty or early adulthood and experience disease progression through the fourth decade. Prevalence in the general population is reported as ranging from 50 to 230 per 100,000 [<a href="#rid1">1-3</a>]. A 2020 meta-analysis that reviewed data for 7,158,241 participants from 15 countries reported a prevalence of 138 per 100,000 persons [<a href="#rid4">4</a>]. There is no significant sex difference in incidence and prevalence [<a href="#rid1">1-6</a>]. Some evidence suggests a higher incidence in Asian people from the Indian subcontinent [<a href="#rid7">7,8</a>]. Another study did not support the association between Asian persons and keratoconus. However, the study did find that Black and Latino persons have approximately 50 percent higher odds of having keratoconus when compared with White persons [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H7023376"><span class="h1">RISK FACTORS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic disorders</strong> – Several studies have linked keratoconus to systemic disorders including Down syndrome, Ehlers-Danlos syndrome, and osteogenesis imperfecta [<a href="#rid9">9,10</a>]. For example, one study of 110 persons with Down syndrome reported that 31 to 39 percent were found to have keratoconus when screened with corneal topography [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Environment</strong> – Atopic disease, asthma, and hay fever have been associated with keratoconus; however, not all studies have found an association [<a href="#rid3">3,10,11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Eye-rubbing</strong> – Reports based on clinical observation have implicated eye rubbing as a risk factor for keratoconus [<a href="#rid10">10,11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> – The number of pairs of identical twins with the disease suggest that a genetic abnormality may be one of several factors involved in the etiology of this disorder [<a href="#rid12">12,13</a>]. A family history of keratoconus has been reported in 6 to 8 percent of cases, but the definitive role of inheritance patterns has not been determined. This disorder has weak penetrance and significant variability of expression [<a href="#rid14">14</a>].</p><p></p><p class="headingAnchor" id="H7023382"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Keratoconus is a noninflammatory disorder of the cornea. Keratoconic corneas have lower collagen content compared with normal corneas [<a href="#rid6">6</a>]. The corneas of patients with keratoconus demonstrate abnormalities in their molecular structure, but a specific biochemical disease pattern has not been established. Similar molecular changes are seen in eyes with corneal scars, suggesting that these changes could be secondary to the disease sequela [<a href="#rid15">15</a>]. The corneal thinning seen in keratoconus is possibly the result of a multifactorial degradation process that results in the loss of structural elements of the cornea. The cause of this thinning is not clear [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H7023388"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Patients present at puberty or early adulthood with blurry vision or a sudden decrease in visual acuity. Symptoms progress until the fourth decade. While vision is initially corrected by spectacles, as the disease progresses, patients may develop irregular astigmatism and require contact lenses for refractive correction.</p><p>Clinical features which may more specifically suggest the diagnosis include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Asymmetric visual complaints</strong> – Although keratoconus is usually a bilateral disease, patients may present with asymmetric symptoms as one eye may be much more severely affected than the other. One study in 64 patients reported that 41 percent had unilateral disease at the time of diagnosis [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Difficulty with visual correction</strong> – As the disease progresses, patients experience difficulties with their spectacle correction and contact lens fitting. Patients may require frequent changes in spectacles due to progressive myopia and astigmatism.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Munson's sign</strong> – In advanced keratoconus, patients may have a v-shaped indentation of the lower eyelid on downgaze caused by a large protuberant cone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Corneal hydrops</strong> – As keratoconus progresses, some patients can present with photophobia and a sudden painful drop in visual acuity that is due to corneal hydrops. The symptoms are caused by the sudden onset of severe corneal edema caused by tears in the Descemet membrane and loss of functionality of the endothelium as a result.</p><p></p><p class="bulletIndent1">Corneal hydrops may occur in about 3 percent of patients with keratoconus. The mean age of onset of corneal hydrops is 25 years of age and is thought to be more common in men [<a href="#rid16">16</a>]. The treatment of corneal hydrops is discussed below. (See <a class="local">'Corneal hydrops treatment'</a> below.)</p><p></p><p class="headingAnchor" id="H7023394"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Although no one finding can definitely establish the presence of keratoconus, ophthalmologists are able to diagnose it by history and clinical exam. The signs and symptoms vary depending on the stage of the disorder.</p><p>Early in the disease, the ophthalmologist may suspect keratoconus because of difficulty correcting a patient’s vision to 20/20 visual acuity. The cornea may appear normal on slit lamp examination, but other methods may aid in the diagnosis of keratoconus. For example, keratometry may show distorted mires centrally or inferiorly [<a href="#rid2">2,3</a>]. Newer technologies, such as corneal topography, can also assist in making the diagnosis and evaluating disease progression [<a href="#rid17">17</a>].</p><p>As the disease progresses, slit lamp findings become common and include (see  <a class="medical medical_review" href="/d/html/259.html" rel="external">"Slit lamp examination"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fleisher ring</strong> – Brown-colored staining around the base of the cone is a subtle early sign and can be noted even when the cone is minimally elevated. It is composed of iron deposited within the epithelium by the tear film. The iron flows with the tear film around the base of the cone. The ring is best seen with the cobalt blue filter on the slit lamp.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vogt striae</strong> – Vogt striae are vertical stress lines in the thinnest part of the cornea at the level of the posterior stroma and Descemet membrane. Unlike Haab striae and folds secondary to corneal edema, Vogt striae disappear when gentle pressure is applied to the cornea.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central and inferior paracentral corneal thinning</strong> – Central and inferior paracentral corneal thinning, along with mild cone formation and protrusion, is an early manifestation of keratoconus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Corneal scarring</strong> – Corneal scarring is the result of spontaneous breaks in Bowman's layer as the cornea thins (<a class="graphic graphic_picture graphicRef105328" href="/d/graphic/105328.html" rel="external">picture 2</a>). It is estimated that 20 percent of patients with keratoconus will have corneal scarring [<a href="#rid18">18</a>].</p><p></p><p>Ophthalmologists may use other technologies in the diagnosis and evaluation of keratoconus:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Retinoscopy</strong> – The scissoring reflex is<strong> </strong>an early sign of developing keratoconus seen on retinoscopy. The ophthalmologist may see two light bands moving towards and then away from each other, similar to the action seen with scissors. The reflex is due to irregular astigmatism.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Keratometry</strong> – Keratometry may demonstrate irregular mires and progressive corneal steepening [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Corneal topography or tomography</strong> – The introduction of corneal topography has helped in the identification of subtle presentations, which can lead to an earlier diagnosis. Major topographic patterns found in keratoconus include asymmetric bowtie, with or without inferior steepening, and skewed radial axes [<a href="#rid19">19</a>]. Corneal tomography is another form of imaging that also allow for measurement of corneal thickness along with local steepness. Once the diagnosis is made, serial corneal topography/tomography is warranted, with frequency dependent on age to monitor for progression [<a href="#rid20">20</a>].</p><p></p><p class="headingAnchor" id="H850729306"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Keratoconus is distinguished from progressive myopia by the clinical examination findings discussed above.</p><p>The ophthalmologist may also consider other ectatic disorders of the cornea in the differential diagnosis of keratoconus. These include keratoglobus and pellucid marginal degeneration [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H7023406"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Corneal collagen cross-linking is recommended for the management of progressive keratoconus or ectasia after refractive surgery. Progression is defined by steepening of anterior cornea surface, steepening of posterior corneal surface, or thinning. Crosslinking is not indicated for cases of keratoconus that present or are recognized in later decades and are stable, or in cases of keratoconus in younger patients that are stable. Crosslinking has been shown to slow the progression by strengthening collagen fibers. The goal of crosslinking is not vision correction; the goal is stabilization of disease. In patients with stable disease, advanced ectatic disease (cornea is too thin), or severe scarring, correction of visual impairment may require spectacles, contact lenses, or surgical interventions.</p><p class="headingAnchor" id="H1399093770"><span class="h2">Collagen cross-linking</span><span class="headingEndMark"> — </span>Collagen cross-linking is a procedure that uses riboflavin drops, ultraviolet light, and a photosensitizer to strengthen bonds in the cornea.</p><p>In a multicenter trial comparing collagen cross-linking to riboflavin drops alone in over 200 patients with progressive keratoconus, improvements in the maximum keratometry value, as well as in corrected and uncorrected distance visual acuity were noted in the treatment group at one year [<a href="#rid22">22</a>]. Earlier trials and cohort studies of collagen cross-linking demonstrated flattening of the cornea and improvement in visual, topographic, and wavefront parameters that were maintained for up to seven years [<a href="#rid23">23-25</a>].</p><p>The procedure is generally safe, but transient corneal haze, keratitis, corneal edema, pain, and blurred vision are not uncommon, with resolution occurring between one and six months after the procedure [<a href="#rid26">26</a>].<strong> </strong>Rarely, corneal haze is reported after 12 months [<a href="#rid27">27</a>].</p><p>Collagen cross-linking is generally not performed in patients with active or history of herpes simplex virus (HSV) keratitis, thin corneas, or corneal hydrops.</p><p class="headingAnchor" id="H9832914"><span class="h2">Correction of vision</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spectacles</strong> – In the early stages, the treatment of choice is spectacle correction. These are used as long as the visual acuity allows the patient to function.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contact lens</strong> – As the disease progresses and irregular astigmatism increases, contact lenses may become necessary to maximize the patient’s visual acuity. A large portion of patients with keratoconus can be managed conservatively with contact lenses for an extended period of time [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/6906.html" rel="external">"Overview of contact lenses"</a>.)</p><p></p><p class="bulletIndent1">Rigid gas-permeable corneal lenses are the most common contact lens used in keratoconus. The rigid structure allows tears to collect behind the lens, resulting in a spherical shape at the corneal plane [<a href="#rid28">28</a>]. The contact lens neutralizes the irregularity of the cornea with its rigid, regular optical surface. In some patients, particularly if the scarring is irregular or elevated, rigid gas-permeable contact lens wear can become intolerable. For those patients, hybrid lenses (rigid lens in the center with a soft skirt peripherally), piggyback lenses, or scleral lenses may be an option [<a href="#rid28">28,29</a>].</p><p></p><p class="bulletIndent1">Scleral lenses are rigid gas permeable lenses that sit gently on the sclera without touching the cornea. The lens reservoir is filled with preservative-free <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> before placing it in the eye [<a href="#rid29">29</a>]. Benefits include improved comfort and less risk of scar formation or worsening, so much so as to reduce the need for corneal transplants in severe keratoconus [<a href="#rid30">30,31</a>].</p><p></p><p class="bulletIndent1">Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) is a nonsurgical treatment model that uses a computer- and software-designed custom prosthetic device [<a href="#rid32">32</a>]. In one study, patients fitted with this type of scleral lens achieved better and more rapid visual acuity compared with patients that had undergone corneal transplantation [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical interventions</strong> – Intrastromal corneal ring segments were approved by the US Food and Drug Administration (FDA) in 2004 for the management of keratoconus. This technique has also been studied in combination with collagen cross-linking [<a href="#rid34">34</a>]. These thin, semicircular plastic inserts are implanted into the mid-corneal layers to flatten the cornea. The goal is to improve the patient’s visual acuity by reducing the amount of astigmatism. Several authors have reported flattening of the cornea and significant improvement of refractive errors [<a href="#rid35">35,36</a>]. However, this treatment is not useful in patients with more advanced vision loss.</p><p></p><p class="bulletIndent1">Keratectomy is uncommonly used in the treatment of corneal scars and nodules to improve contact lens tolerance. However, recurrence is possible and can stimulate progression [<a href="#rid37">37,38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Keratoplasty (corneal transplantation)</strong> – Keratoplasty is the procedure of choice when contact lenses are no longer helpful. Approximately 10 to 15 percent of patients with keratoconus will require keratoplasty; penetrating keratoplasty (full thickness corneal transplant) is the most commonly used procedure [<a href="#rid39">39,40</a>]. This procedure has a success rate of greater than 90 percent in patients with keratoconus [<a href="#rid41">41</a>]. Studies have reported visual acuity of 20/40 or better in 80 to 90 percent of patients [<a href="#rid41">41-43</a>]. Of those patients, 15 percent obtain that visual acuity without correction, 40 percent with spectacle correction, and 26 percent with contact lenses. Graft rejection has been reported in 20 to 35 percent of cases in the first 12 months after surgery. It is associated with loose sutures, trauma, and large grafts [<a href="#rid41">41</a>]. The majority of cases are treated successfully with corticosteroids. A more common complication of penetrating keratoplasty is astigmatism. Treatment options for astigmatism include contact lens correction, refractive surgery, relaxing incisions, wedge resection, and compressive sutures.</p><p></p><p class="bulletIndent1">Deep anterior lamellar keratoplasty (partial thickness corneal transplant) is another option for keratoplasty that may be used in the treatment of keratoconus [<a href="#rid40">40,44</a>]. It is used infrequently in the United States.</p><p></p><p class="headingAnchor" id="H15348212"><span class="h2">Corneal hydrops treatment</span><span class="headingEndMark"> — </span>Corneal hydrops generally resolves without intervention over two to four months, although the patient will experience discomfort and compromised vision during that time [<a href="#rid5">5,16,45</a>]. As the tears in Descemet’s membrane heal, endothelial function returns and the corneal edema gradually lessens.</p><p>Evidence about effective treatment is lacking [<a href="#rid16">16</a>]. Treatments include pressure patching and bandage contact lenses as well as topical hyperosmotics, cycloplegics, and steroids in an attempt to decrease edema, pain, and inflammation. Intracameral perfluoropropane gas injection has been found to decrease the time to resolution of hydrops but does not change the outcome in terms of visual acuity or need for corneal transplantation. Corneal perforation is very rare. Keratoplasty is not indicated in the acute stage.</p><p>After an episode of corneal hydrops, the cornea is left with a scar [<a href="#rid3">3,10</a>]. Paradoxically, the severity of the cone may be reduced as the cornea flattens. This may result in reduced and more manageable astigmatism. Eventually, however, patients may require keratoplasty because of corneal scarring as a result of hydrops.</p><p class="headingAnchor" id="H7023412"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Keratoconus is a progressive condition. In a 2019 meta-analysis of the natural history of keratoconus, factors associated with a higher likelihood of progression included younger age and keratometry measurements steeper than 55 diopters at presentation [<a href="#rid46">46</a>]. Other factors associated with progression are corneal scaring and worsening visual acuity [<a href="#rid18">18,39</a>]. One study reported a 12 percent rate of keratoplasty over eight years of follow-up [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H7023424"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Keratoconus is a noninflammatory disorder of the cornea. It is characterized by progressive thinning and cone-shaped protrusion of the cornea leading to visual impairment. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Keratoconus is more common in those with a family history of the disorder. It has also been found to be associated with certain systemic disorders. Contact lens use is not clearly a risk factor. Some observations implicate eye rubbing. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients present at puberty or early adulthood with vision impairment that may be asymmetric. Vision impairment progresses until the fourth decade. Difficulty with vision correction may be the first indication of this disorder. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Corneal hydrops may be seen in advanced keratoconus. It is caused by sudden onset of severe corneal edema that can lead to a sudden, painful drop in visual acuity. This typically resolves over a few months. While there is limited evidence for effective treatments, symptomatic therapies are often tried. (See <a class="local">'Clinical features'</a> above and <a class="local">'Corneal hydrops treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Corneal collagen cross-linking is suggested for the management of progressive keratoconus (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). It has been shown to slow the progression by strengthening collagen fibers. It is not recommended for patients with advanced disease. In some patients with keratoconus, correction of visual impairment may also require spectacles, contact lenses, or surgical interventions. (See <a class="local">'Management'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 1984; 28:293.</a></li><li><a class="nounderline abstract_t">Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 1986; 101:267.</a></li><li><a class="nounderline abstract_t">Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998; 42:297.</a></li><li><a class="nounderline abstract_t">Hashemi H, Heydarian S, Hooshmand E, et al. The Prevalence and Risk Factors for Keratoconus: A Systematic Review and Meta-Analysis. Cornea 2020; 39:263.</a></li><li><a class="nounderline abstract_t">Vazirani J, Basu S. Keratoconus: current perspectives. Clin Ophthalmol 2013; 7:2019.</a></li><li><a class="nounderline abstract_t">Jhanji V, Sharma N, Vajpayee RB. Management of keratoconus: current scenario. Br J Ophthalmol 2011; 95:1044.</a></li><li><a class="nounderline abstract_t">Georgiou T, Funnell CL, Cassels-Brown A, O'Conor R. Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asians and white patients. Eye (Lond) 2004; 18:379.</a></li><li><a class="nounderline abstract_t">Pearson AR, Soneji B, Sarvananthan N, Sandford-Smith JH. Does ethnic origin influence the incidence or severity of keratoconus? Eye (Lond) 2000; 14 ( Pt 4):625.</a></li><li><a class="nounderline abstract_t">Woodward MA, Blachley TS, Stein JD. The Association Between Sociodemographic Factors, Common Systemic Diseases, and Keratoconus: An Analysis of a Nationwide Heath Care Claims Database. Ophthalmology 2016; 123:457.</a></li><li><a class="nounderline abstract_t">Sugar J, Macsai MS. What causes keratoconus? Cornea 2012; 31:716.</a></li><li><a class="nounderline abstract_t">Mathan JJ, Gokul A, Simkin SK, et al. Topographic screening reveals keratoconus to be extremely common in Down syndrome. Clin Exp Ophthalmol 2020; 48:1160.</a></li><li><a class="nounderline abstract_t">Hartstein J. Keratoconus that developed in patients wearing corneal contact lenses. Report of four cases. Arch Ophthalmol 1968; 80:345.</a></li><li><a class="nounderline abstract_t">Gasset AR, Houde WL, Garcia-Bengochea M. Hard contact lens wear as an environmental risk in keratoconus. Am J Ophthalmol 1978; 85:339.</a></li><li><a class="nounderline abstract_t">Goldring MB, Krane SM. Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem 1987; 262:16724.</a></li><li><a class="nounderline abstract_t">Sawaguchi S, Yue BY, Chang I, et al. Proteoglycan molecules in keratoconus corneas. Invest Ophthalmol Vis Sci 1991; 32:1846.</a></li><li><a class="nounderline abstract_t">Fan Gaskin JC, Patel DV, McGhee CN. Acute corneal hydrops in keratoconus - new perspectives. Am J Ophthalmol 2014; 157:921.</a></li><li><a class="nounderline abstract_t">Fernández Pérez J, Valero Marcos A, Martínez Peña FJ. Early diagnosis of keratoconus: what difference is it making? Br J Ophthalmol 2014; 98:1465.</a></li><li><a class="nounderline abstract_t">Wagner H, Barr JT, Zadnik K. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye 2007; 30:223.</a></li><li><a class="nounderline abstract_t">Rabinowitz YS. Videokeratographic indices to aid in screening for keratoconus. J Refract Surg 1995; 11:371.</a></li><li><a class="nounderline abstract_t">Gomes JA, Tan D, Rapuano CJ, et al. Global consensus on keratoconus and ectatic diseases. Cornea 2015; 34:359.</a></li><li class="breakAll">American Academy of Ophthalmology. 2007-2008 Basic and Clinical Science Course Section 8: External Disease and Cornea, Sutphin JE (Ed), 2007. p.329.</li><li><a class="nounderline abstract_t">Hersh PS, Stulting RD, Muller D, et al. United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment. Ophthalmology 2017; 124:1259.</a></li><li><a class="nounderline abstract_t">Sykakis E, Karim R, Evans JR, et al. Corneal collagen cross-linking for treating keratoconus. Cochrane Database Syst Rev 2015; :CD010621.</a></li><li><a class="nounderline abstract_t">Koller T, Pajic B, Vinciguerra P, Seiler T. Flattening of the cornea after collagen crosslinking for keratoconus. J Cataract Refract Surg 2011; 37:1488.</a></li><li><a class="nounderline abstract_t">O'Brart DP, Patel P, Lascaratos G, et al. Corneal Cross-linking to Halt the Progression of Keratoconus and Corneal Ectasia: Seven-Year Follow-up. Am J Ophthalmol 2015; 160:1154.</a></li><li><a class="nounderline abstract_t">Dhawan S, Rao K, Natrajan S. Complications of corneal collagen cross-linking. J Ophthalmol 2011; 2011:869015.</a></li><li><a class="nounderline abstract_t">Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg 2009; 25:S824.</a></li><li><a class="nounderline abstract_t">Nau AC. A comparison of synergeyes versus traditional rigid gas permeable lens designs for patients with irregular corneas. Eye Contact Lens 2008; 34:198.</a></li><li><a class="nounderline abstract_t">Rathi VM, Mandathara PS, Dumpati S. Contact lens in keratoconus. Indian J Ophthalmol 2013; 61:410.</a></li><li><a class="nounderline abstract_t">Schornack MM. Scleral lenses: a literature review. Eye Contact Lens 2015; 41:3.</a></li><li><a class="nounderline abstract_t">Koppen C, Kreps EO, Anthonissen L, et al. Scleral Lenses Reduce the Need for Corneal Transplants in Severe Keratoconus. Am J Ophthalmol 2018; 185:43.</a></li><li><a class="nounderline abstract_t">Baran I, Bradley JA, Alipour F, et al. PROSE treatment of corneal ectasia. Cont Lens Anterior Eye 2012; 35:222.</a></li><li><a class="nounderline abstract_t">DeLoss KS, Fatteh NH, Hood CT. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia. Am J Ophthalmol 2014; 158:974.</a></li><li><a class="nounderline abstract_t">Iovieno A, Légaré ME, Rootman DB, et al. Intracorneal Ring Segments Implantation Followed By Same-day Photorefractive Keratectomy and Corneal Collagen Cross-linking in Keratoconus. J Refract Surg 2011; 27:915.</a></li><li><a class="nounderline abstract_t">Colin J, Cochener B, Savary G, Malet F. Correcting keratoconus with intracorneal rings. J Cataract Refract Surg 2000; 26:1117.</a></li><li><a class="nounderline abstract_t">Tu KL, Sebastian RT, Owen M, et al. Quantification of the surgically induced refractive effect of intrastromal corneal ring segments in keratoconus with standardized incision site and segment size. J Cataract Refract Surg 2011; 37:1865.</a></li><li><a class="nounderline abstract_t">Moodaley L, Buckley RJ, Woodward EG. Surgery to improve contact lens wear in keratoconus. CLAO J 1991; 17:129.</a></li><li><a class="nounderline abstract_t">Moodaley L, Liu C, Woodward EG, et al. Excimer laser superficial keratectomy for proud nebulae in keratoconus. Br J Ophthalmol 1994; 78:454.</a></li><li><a class="nounderline abstract_t">Gordon MO, Steger-May K, Szczotka-Flynn L, et al. Baseline factors predictive of incident penetrating keratoplasty in keratoconus. Am J Ophthalmol 2006; 142:923.</a></li><li><a class="nounderline abstract_t">Keane M, Coster D, Ziaei M, Williams K. Deep anterior lamellar keratoplasty versus penetrating keratoplasty for treating keratoconus. Cochrane Database Syst Rev 2014; :CD009700.</a></li><li><a class="nounderline abstract_t">Sharif KW, Casey TA. Penetrating keratoplasty for keratoconus: complications and long-term success. Br J Ophthalmol 1991; 75:142.</a></li><li><a class="nounderline abstract_t">Price FW Jr, Whitson WE, Marks RG. Graft survival in four common groups of patients undergoing penetrating keratoplasty. Ophthalmology 1991; 98:322.</a></li><li><a class="nounderline abstract_t">Kirkness CM, Ficker LA, Steele AD, Rice NS. The success of penetrating keratoplasty for keratoconus. Eye (Lond) 1990; 4 ( Pt 5):673.</a></li><li><a class="nounderline abstract_t">Kasbekar SA, Jones MN, Ahmad S, et al. Corneal transplant surgery for keratoconus and the effect of surgeon experience on deep anterior lamellar keratoplasty outcomes. Am J Ophthalmol 2014; 158:1239.</a></li><li><a class="nounderline abstract_t">Lockington D, Fan Gaskin JC, McGhee CN, Patel DV. A prospective study of acute corneal hydrops by in vivo confocal microscopy in a New Zealand population with keratoconus. Br J Ophthalmol 2014; 98:1296.</a></li><li><a class="nounderline abstract_t">Ferdi AC, Nguyen V, Gore DM, et al. Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11 529 Eyes. Ophthalmology 2019; 126:935.</a></li></ol></div><div id="topicVersionRevision">Topic 16290 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6230745" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Keratoconus and related noninflammatory corneal thinning disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3513592" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A 48-year clinical and epidemiologic study of keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9493273" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31498247" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The Prevalence and Risk Factors for Keratoconus: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24143069" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Keratoconus: current perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20693553" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Management of keratoconus: current scenario.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15069434" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asians and white patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11040911" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Does ethnic origin influence the incidence or severity of keratoconus?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26707415" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The Association Between Sociodemographic Factors, Common Systemic Diseases, and Keratoconus: An Analysis of a Nationwide Heath Care Claims Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22406940" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : What causes keratoconus?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32876978" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Topographic screening reveals keratoconus to be extremely common in Down syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5670688" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Keratoconus that developed in patients wearing corneal contact lenses. Report of four cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/655213" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Hard contact lens wear as an environmental risk in keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3500170" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2032806" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Proteoglycan molecules in keratoconus corneas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24491416" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Acute corneal hydrops in keratoconus - new perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24759873" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Early diagnosis of keratoconus: what difference is it making?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17481941" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8528916" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Videokeratographic indices to aid in screening for keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25738235" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Global consensus on keratoconus and ectatic diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25738235" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Global consensus on keratoconus and ectatic diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28495149" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25803325" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Corneal collagen cross-linking for treating keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21782091" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Flattening of the cornea after collagen crosslinking for keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26307513" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Corneal Cross-linking to Halt the Progression of Keratoconus and Corneal Ectasia: Seven-Year Follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22254130" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Complications of corneal collagen cross-linking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19772259" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18787425" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A comparison of synergeyes versus traditional rigid gas permeable lens designs for patients with irregular corneas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23925325" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Contact lens in keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25536528" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Scleral lenses: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29103959" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Scleral Lenses Reduce the Need for Corneal Transplants in Severe Keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22633003" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : PROSE treatment of corneal ectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25058902" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22074467" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Intracorneal ring segments implantation followed by same-day photorefractive keratectomy and corneal collagen cross-linking in keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11008037" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Correcting keratoconus with intracorneal rings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21930047" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Quantification of the surgically induced refractive effect of intrastromal corneal ring segments in keratoconus with standardized incision site and segment size.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2049822" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Surgery to improve contact lens wear in keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8060928" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Excimer laser superficial keratectomy for proud nebulae in keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17157577" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Baseline factors predictive of incident penetrating keratoplasty in keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25055058" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Deep anterior lamellar keratoplasty versus penetrating keratoplasty for treating keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1826453" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Penetrating keratoplasty for keratoconus: complications and long-term success.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2023753" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Graft survival in four common groups of patients undergoing penetrating keratoplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2282941" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The success of penetrating keratoplasty for keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25174894" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Corneal transplant surgery for keratoconus and the effect of surgeon experience on deep anterior lamellar keratoplasty outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24782467" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A prospective study of acute corneal hydrops by in vivo confocal microscopy in a New Zealand population with keratoconus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30858022" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11 529 Eyes.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
